LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 97 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4 | -95.8% | 3,555 | -94.7% | 0.00% | – |
| Q2 2023 | $95 | -90.5% | 67,600 | +7353.1% | 0.00% | – |
| Q2 2022 | $1,000 | -99.1% | 907 | -98.7% | 0.00% | – |
| Q1 2022 | $106,000 | -37.3% | 69,129 | +0.3% | 0.00% | – |
| Q4 2021 | $169,000 | -2.9% | 68,922 | -0.3% | 0.00% | – |
| Q3 2021 | $174,000 | -41.2% | 69,150 | -33.4% | 0.00% | – |
| Q2 2021 | $296,000 | +410.3% | 103,900 | +49.5% | 0.00% | – |
| Q1 2020 | $58,000 | -6.5% | 69,500 | 0.0% | 0.00% | – |
| Q4 2019 | $62,000 | -8.8% | 69,500 | 0.0% | 0.00% | – |
| Q3 2019 | $68,000 | – | 69,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 34,935,485 | $55,198,000 | 4.16% |
| Raffles Associates | 1,930,536 | $3,050,000 | 3.32% |
| Defender Capital, LLC. | 5,131,935 | $8,108,000 | 3.18% |
| Prescott General Partners LLC | 1,851,851 | $2,926,000 | 0.20% |
| DAFNA Capital Management LLC | 140,000 | $221,000 | 0.06% |
| Laurion Capital Management LP | 2,422,367 | $3,827,000 | 0.06% |
| Beirne Wealth Consulting Services, LLC | 45,000 | $71,000 | 0.05% |
| Fort Sheridan Advisors LLC | 78,931 | $125,000 | 0.04% |
| Long Focus Capital Management, LLC | 215,000 | $340,000 | 0.04% |
| MORGAN JESS S & CO INC | 20,000 | $32,000 | 0.03% |